CARL ZEISS MEDITEC AG overview

Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market PR Newswire JENA, Germany and DUBLIN, Calif., April 4, 2024 ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion strategy for ophthalmic medical devices and surgery. JENA, Germany and DUBLIN, Calif. , April 4, 2024 /PRNewswire/ -- Carl Zeiss...

Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market PR Newswire JENA, Germany and DUBLIN, Calif., April 4, 2024 ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion strategy for ophthalmic medical devices and surgery. JENA, Germany and DUBLIN, Calif. , April 4, 2024 /PRNewswire/ -- Carl Zeiss...

EQS-News: Carl Zeiss Meditec AG / Key word(s): Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24 09.02.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24 Decline in profit due to expected weaker product mix JENA, 9 February 2024 Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of...

EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Share Buyback Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m 29-Jan-2024 / 11:11 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m Jena, 29...

EQS-News: Carl Zeiss Meditec AG / Key word(s): Regulatory Approval U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS 11.01.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements. DUBLIN, CA (USA) / JENA, Germany | January...